Introduction: Traditional diagnosis and classification of inflammatory bowel diseases (IBDs)
have been based on clinical evaluation, laboratory testing, endoscopy, imaging, and …

Introduction: Diagnosis of the chronic inflammatory bowel diseases relies upon initial
recognition of an inflammatory condition, followed by definitive endoscopic, histological and …

Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of
biological and morphological tests. The current method of diagnostic remains a critical …

In inflammatory bowel diseases (IBDs), such as Crohn's disease (CD) and ulcerative colitis
(UC), the immune system relentlessly attacks intestinal cells, causing recurrent tissue …

Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …

There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …

Genetic factors play a significant role in determining inflammatory bowel disease (IBD)
susceptibility. Epidemiologic data support genetic contribution to the pathogenesis of IBD …

Mucosal healing (MH) is the main treatment target in ulcerative colitis (UC) and Crohn's
disease, and it is defined by the combination of complete endoscopic and histologic …

Biomarkers in inflammatory bowel disease : Current Opinion in Gastroenterology Biomarkers
in inflammatory bowel disease : Current Opinion in Gastroenterology Log in or Register …

Crohn's disease and ulcerative colitis represent the two main forms of the idiopathic chronic
inflammatory bowel diseases (IBD). Currently available blood and stool based biomarkers …